欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号NO/H/0250/001
药品名称Lisinopril EssPharm
活性成分
    • Lisinopril dihydrate 1.0 mg/ml
剂型Oral solution
上市许可持有人Essential Pharmaceuticals Ltd 7 Egham Business Village Crabtree Road, Egham, Surrey TW 20 8RB United Kingdom
参考成员国 - 产品名称Norway (NO)
Lisinopril EssPharm
互认成员国 - 产品名称
    • Belgium (BE)
      Lisinopril TAW Pharma 1mg/ml solution buvable
    • Netherlands (NL)
    • Luxembourg (LU)
    • United Kingdom (Northern Ireland) (XI)
    • Ireland (IE)
    • Austria (AT)
      Lisinopril Essential Pharmaceuticals 1 mg/ml Lösung zum Einnehmen
许可日期2015/06/29
最近更新日期2024/10/24
药物ATC编码
    • C09AA03 lisinopril
申请类型
  • TypeLevel1:Known Active Substance
  • TypeLevel2:Initial Application
  • TypeLevel3:Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase